236 related articles for article (PubMed ID: 38177502)
1. Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression.
Bahcheli AT; Min HK; Bayati M; Zhao H; Fortuna A; Dong W; Dzneladze I; Chan J; Chen X; Guevara-Hoyer K; Dirks PB; Huang X; Reimand J
EMBO J; 2024 Jan; 43(2):196-224. PubMed ID: 38177502
[TBL] [Abstract][Full Text] [Related]
2. Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
Pollak J; Rai KG; Funk CC; Arora S; Lee E; Zhu J; Price ND; Paddison PJ; Ramirez JM; Rostomily RC
PLoS One; 2017; 12(3):e0172884. PubMed ID: 28264064
[TBL] [Abstract][Full Text] [Related]
3. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
[TBL] [Abstract][Full Text] [Related]
4. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Fatai AA; Gamieldien J
BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
[TBL] [Abstract][Full Text] [Related]
6. Sodium ion channel mutations in glioblastoma patients correlate with shorter survival.
Joshi AD; Parsons DW; Velculescu VE; Riggins GJ
Mol Cancer; 2011 Feb; 10():17. PubMed ID: 21314958
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.
Isaev K; Jiang L; Wu S; Lee CA; Watters V; Fort V; Tsai R; Coutinho FJ; Hussein SMI; Zhang J; Wu J; Dirks PB; Schramek D; Reimand J
Cell Rep; 2021 Oct; 37(3):109873. PubMed ID: 34686327
[TBL] [Abstract][Full Text] [Related]
8. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
Li D; Lu J; Li H; Qi S; Yu L
Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
[TBL] [Abstract][Full Text] [Related]
9. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells.
Campbell TM; Main MJ; Fitzgerald EM
J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
12. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma.
Mucaj V; Lee SS; Skuli N; Giannoukos DN; Qiu B; Eisinger-Mathason TS; Nakazawa MS; Shay JE; Gopal PP; Venneti S; Lal P; Minn AJ; Simon MC; Mathew LK
Oncogene; 2015 Apr; 34(17):2204-14. PubMed ID: 24954504
[TBL] [Abstract][Full Text] [Related]
14. Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma.
Lu A; Shi Y; Liu Y; Lin J; Zhang H; Guo Y; Li L; Lin Z; Wu J; Ji D; Wang C
Lung Cancer; 2021 Aug; 158():29-39. PubMed ID: 34111567
[TBL] [Abstract][Full Text] [Related]
15. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
[TBL] [Abstract][Full Text] [Related]
16. Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1.
Xia J; Huang N; Huang H; Sun L; Dong S; Su J; Zhang J; Wang L; Lin L; Shi M; Bin J; Liao Y; Li N; Liao W
Int J Cancer; 2016 Dec; 139(11):2553-69. PubMed ID: 27529686
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.
Eisemann T; Costa B; Harter PN; Wick W; Mittelbronn M; Angel P; Peterziel H
Neuro Oncol; 2019 Feb; 21(3):326-336. PubMed ID: 30418623
[TBL] [Abstract][Full Text] [Related]
18. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
19. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
[TBL] [Abstract][Full Text] [Related]
20. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
